Lobbying Activity Report

504-25476

Organization: B.C. Pharmacy Association
Associated registration: 2214-504-28
Lobbying Activity date: 2023-03-01
Arranged a meeting: Yes
Posted date: 2023-04-15

In-house lobbyists who participated in the lobbying activity: Michael Mui
Senior Public Office Holders who were lobbied in this activity: Pam Alexis, MLA for Abbotsford-Mission
Member(s) of the BC Legislative Assembly

Michele Babchuk, MLA for North Island
Member(s) of the BC Legislative Assembly

Brenda Bailey, MLA for Vancouver-False Creek
Member(s) of the BC Legislative Assembly

Shirley Bond, MLA for Prince George-Valemount
Member(s) of the BC Legislative Assembly

Nathan Cullen, MLA for Stikine
Member(s) of the BC Legislative Assembly

Mike Farnworth, MLA for Port Coquitlam
Member(s) of the BC Legislative Assembly

Rob Fleming, MLA for Victoria-Swan Lake
Member(s) of the BC Legislative Assembly

Grace Lore, MLA for Victoria-Beacon Hill
Member(s) of the BC Legislative Assembly

Bowinn Ma, MLA for North Vancouver-Lonsdale
Member(s) of the BC Legislative Assembly

Andrew Mercier, MLA for Langley
Member(s) of the BC Legislative Assembly

Murray Rankin, MLA for Oak Bay-Gordon Head
Member(s) of the BC Legislative Assembly

Niki Sharma, MLA for Vancouver-Hastings
Member(s) of the BC Legislative Assembly

Todd Stone, MLA for Kamloops-South Thompson
Member(s) of the BC Legislative Assembly

Jennifer Whiteside, MLA for New Westminster
Member(s) of the BC Legislative Assembly
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Advocating for pharmacists' role in Suboxone therapy and renewing opioid agonist treatments to help in B.C's response to the opioid overdose crisis.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Mental Health and Addictions
COVID-19 vaccine and testing in community pharmacy
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health
Discussions around the development or amendments to pharmacy programs or policies and the role pharmacists play in primary and public health in the province
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health
Discussions around the development or amendments to pharmacy programs or policies and the role pharmacists play in primary and public health in the province.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health, Mental Health and Addictions
 
Senior officer who filed this Lobbying Activity Report: Geraldine Vance
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: